AzTrials
AzTrials

Patient ComplianceNCT03437980

Propofol Spinal Procedural Sedation for Cesarean Section

A study testing propofol in people with Patient Compliance, run by Mansoura University at 3 sites in Egypt.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Patient's safety and satisfaction are major concerns of anesthesiologists and obstetricians. According to evidence, guidelines and quality markers, regional anesthesia is preferred over general anesthesia in obstetric surgery. A high level of anxiety is present in obstetric patients preoperatively. Read more about this study

Who is it for?
Ages 18 to 40 years, women only
Conditions the study is for
Patient Compliance
What is being tested?
propofol
Type of treatment
Injection or infusion
Could I receive a placebo?
No, everyone receives an active treatment
How many people
228 participants
Where
3 sitesEgypt
Study dates
1 Apr 2018to 10 Sep 2018
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 40 years
  • Women only
  • No healthy volunteers
  • Adult

Who may be able to join

  • Patients scheduled for elective cesarean section,
  • Age: 18 - 40 years,
  • American Society of Anesthesiologists I - III,
  • Patients may present any of the following conditions:
  • Respiratory diseases as bronchial asthma
  • Hepatic compromise,
Show all 11Show fewer
  • Preeclampsia,
  • Anemia with hemoglobin 10 g/dl,
  • Previous sections,
  • Obese with BMI more than 35%,
  • Any criteria of difficult intubation, Compromised fetus as premature delivery, History of complications or non-satisfaction after general anesthesia during previous cesarean section,

Who cannot join

  • Patients refusing to participate in the study,
  • Known psychiatric disease,
  • Addiction medications,
  • Communication barrier,
  • Absolute or relative contraindication for spinal anesthesia,
  • Bad obstetric history, complicated pregnancy, congenital fetal anomaly.

Trial locations and contacts

3 sites in 1 country.

Egypt3 sites
  • Delta Hospital

    Al Mansurah, Dakahlya, 35516

  • Mansoura University Hospital

    Al Mansurah, Dakahlya, 35516

  • Zagazig University Hospital

    Zagazig, Sharkya, 44519

Other trials in Egypt

About this study

Official title: Can Propofol Procedural Sedation Implementation Increase the Acceptance of Spinal Anesthesia During Cesarean Section?

Patient's safety and satisfaction are major concerns of anesthesiologists and obstetricians. According to evidence, guidelines and quality markers, regional anesthesia is preferred over general anesthesia in obstetric surgery. A high level of anxiety is present in obstetric patients preoperatively. Patients with high anxiety tend to prefer general anesthesia for cesarean section. The anxiety can be reduced variably by non-pharmacologic and pharmacologic methods. The evidence supports the benefits of procedural sedation for distressed, anxious pregnant women.

Read the detailed description

Propofol provides short onset, rapid predictable action, anxiolysis and amnesia and it is more effective than benzodiazepines. Using propofol infusion in low doses during spinal injection in CS did not adversely affect the Apgar scores or the neurological and adaptive fetal outcomes. The general consensus is that procedural sedation is not a routine for spinal interventions, but required for anxious patients. Our hypothesis is that, with the high prevalence of maternal anxiety during cesarean section, ensuring painless comfortable spinal anesthesia may increase the acceptance rate of regional anesthesia during cesarean section.

Being tested
propofol
Medical subject headings
Patient Compliance

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • propofolDrug

    Also called propofol procedural sedation

    A bolus of 0.7 mg/kg will be given initially, additional incremental doses of 20 mg propofol will be given if the patient complained of pain or moved arms towards the back. Patients will be sitting on the middle of the operating table facing towards the table's foot. The table's foot will be dropped 45 degrees for a comfortable chair position, Monitoring through pulse oximeter (SaO2), non-invasive blood pressure (NIBP) adjusted every 2 minutes automatic measuring and capnography tube in contact with nostrils.

Study groups in NCT03437980
Study groupRoleWhat they receive
propofol spinal acceptanceExperimentalThe surgeon and the anesthetist will discuss the exclusion criteria. Then they will discuss the information's about spinal and general anesthesia with the illegible patients, also reply the patient's questions in a preoperative visit. The primary decision for the patient; either spinal or general anesthesia will be recorded. The patients refusing spinal anesthesia will be discussed again to detect the rate of acceptance of spinal anesthesia if propofol sedation is ensured during the procedure to provide a painless spinal injection. The final decision will be applied; either spinal with procedural sedation, or general anesthesia.
Receives: Drug: propofol

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. The rate of acceptance of spinal anesthesia if propofol sedation is added during the procedure.

    percent

    Measured: 30 minutes preoperative.

Secondary outcomes (2)
  1. The rate of initial acceptance of spinal anesthesia without sedation.

    percent

    Measured: 30 minutes preoperative.

  2. The anxiety score.

    by the visual analogue score from 0-10, where 10 is the maximum anxiety level.

    Measured: 30 minutes preoperative,10 minutes after spinal injection, and 30 minutes after stay at recovery room.

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted19 Feb 2018
  2. Study start1 Apr 2018
  3. Primary completion10 Jul 2018
  4. Study completion10 Sep 2018

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Supportive care
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrolment
228 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03437980
Sponsor's protocol ID
R.18.02.23
Status last verified
Sep 2020
First submitted
4 Feb 2018
Last updated
18 Sep 2020
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided

Questions about this trial

What is this clinical trial studying?

A study testing propofol in people with Patient Compliance, run by Mansoura University at 3 sites in Egypt.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 11 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 18 Sep 2020. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 3 sites in Egypt. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

The rate of acceptance of spinal anesthesia if propofol sedation is added during the procedure. (time frame: 30 minutes preoperative.). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 18 Sep 2020.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in